CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/education

education organization

University of Leeds

GB

OPENALEX: I130828816↗ROR: 024mrxd33↗

People

Connected researchers

Abdulla WatadORCID 0000-0002-1404-8027 Alastair G. CardnoORCID 0000-0002-6136-5965 Chris TwelvesORCID 0000-0002-1849-7153 Mark MonaghanORCID 0000-0002-8650-6314 Mark WallaceORCID 0000-0001-5647-6233 Pak C. ShamORCID 0000-0002-2533-7270

Public evidence

5 connected articles

First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data2023 · PubMed Central Open Access Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.2021 · PubMed Central Open Access The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.2021 · PubMed Central Open Access Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study.2019 · PubMed Central Open Access Psychotic experiences are linked to cannabis use in adolescents in the community because of common underlying environmental risk factors2015 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.

University of Leeds - Medical Cannabis Research Engine